Ads
related to: doxofylline for asthma symptoms in adults chest pain medication algorithmwalmart.com has been visited by 1M+ users in the past month
Search results
Results from the WOW.Com Content Network
Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in the treatment of chronic respiratory diseases such as asthma [1] and COPD. [2] Like theophylline, it is a xanthine derivative. [3] [4]
Frequent coughing, chest tightness and breathing difficulties are also signs of asthma worsening. These symptoms can interfere with a patient's daily living and affect quality of life. These 5 levels are indicators of what drug treatments should be administered. The guideline is as follows: [2] Step 1-2: Symptoms less than 4–5 days a week
Because it has no effect on asthma symptoms when used alone, it is most often paired with a short-acting β 2-adrenergic agonist. While it is considered a relief or rescue medication, it can take a full hour to begin working. For this reason, it plays a secondary role in acute asthma treatment. Dry throat is the most common side effect.
For premium support please call: 800-290-4726 more ways to reach us
ChestEze (or Do-Do ChestEze) is a British over-the-counter pharmaceutical product manufactured by Novartis [1] for "relief of bronchial cough, wheezing, breathlessness and other symptoms of asthmatic bronchitis and to clear the chest of mucus following upper respiratory tract infection."
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
Ads
related to: doxofylline for asthma symptoms in adults chest pain medication algorithmwalmart.com has been visited by 1M+ users in the past month